Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07595614

NLP Analysis of Weekly Narratives for Dynamic Clinical Assessment in SUD

This prospective observational study follows adults undergoing residential rehabilitation for severe substance use disorders at a specialized treatment center in Mexico. Participants provide weekly written narratives describing their emotions, challenges, coping strategies, and treatment experiences, and complete validated psychological questionnaires every two weeks, including the Generalized Anxiety Disorder-7 (GAD-7), Environmental Reward Observation Scale (EROS), Automatic Thoughts Questionnaire-8 (ATQ-8), and Behavioral Activation for Depression Scale (BADS).

The study applies natural language processing (NLP) and machine learning methods to analyze participants' narratives and identify emotional, cognitive, and behavioral patterns associated with clinical change over time. Narrative-derived features are combined with questionnaire scores to generate a dynamic clinical risk representation that may help detect early signs of psychological worsening or improvement during residential treatment.

Participants continue receiving standard residential care, and the study does not modify treatment decisions or clinical interventions. Up to 35 participants with sufficient longitudinal follow-up data will be included in the primary analysis. Data collection is expected to continue through September 2026.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

Male

Study type

Observational

Primary location

Under The Tree Potrerillos

Potrerillos, Jalisco, 45815, Mexico

Location status: Recruiting

Location contact

Lauro Gutiérrez Castro

CONTACT

[email protected]

+523314696107

About this study

Patients undergoing treatment for substance use disorders frequently describe changes in mood, motivation, hopelessness, cognitive rigidity, emotional distress, and coping strategies through spontaneous written language. These narratives may contain clinically meaningful indicators associated with psychological deterioration, treatment progress, or relapse vulnerability. However, systematic manual analysis of longitudinal written narratives is difficult to implement in routine clinical practice because of the volume and complexity of the data.

Recent developments in natural language processing (NLP), representation learning, and deep learning provide methods for extracting quantitative linguistic and semantic information from written text. Integrating these features with repeated psychometric assessments may support the development of longitudinal models capable of characterizing changes in mental health status over time in patients receiving residential addiction treatment.

Objectives

The objectives of this study are:

To extract semantic, emotional, and linguistic features from weekly patient narratives using NLP methods, including sentence embeddings, sentiment and emotion classification, and semantic similarity analyses based on Acceptance and Commitment Therapy (ACT) constructs.

To integrate narrative-derived variables with repeated psychometric measures (Generalized Anxiety Disorder-7 (GAD-7), Environmental Reward Observation Scale (EROS), Automatic Thoughts Questionnaire-8 (ATQ-8), and Behavioral Activation for Depression Scale (BADS)) using a multimodal deep learning autoencoder capable of generating a low-dimensional representation of longitudinal clinical status.

To evaluate whether latent representations generated by the autoencoder are associated with periods of clinical worsening or clinical improvement across time using leave-one-patient-out cross-validation procedures.

To develop a dynamic longitudinal risk representation capable of estimating future changes in automatic negative thoughts, measured through subsequent ATQ-8 scores.

Study Design

This study is a prospective observational cohort conducted at a single residential rehabilitation center in Mexico.

Eligible participants are adults aged 18 years or older with a diagnosis of severe substance use disorder who are admitted for residential treatment. Individuals with active psychotic symptoms or cognitive impairment that substantially interferes with the ability to complete written narratives are excluded.

Participants complete:

Weekly digital written narratives using open-ended prompts focused on emotions, challenges, coping responses, interpersonal experiences, and perceived treatment progress.

Biweekly administration of the following validated self-report instruments:

GAD-7

EROS

ATQ-8

BADS

All information is collected through digital forms integrated into routine clinical monitoring procedures at the treatment center.

Participants may contribute data for up to 20 weeks, depending on duration of residential stay. The study began on 25 May 2025, and primary completion is anticipated in September 2026.

Up to 35 participants with sufficient longitudinal observations will be included in the primary analytic cohort.

NLP and Machine Learning Pipeline

Text preprocessing

Narratives are written in Spanish and undergo preprocessing procedures that include:

minimum length filtering, normalization, consolidation of narrative fields into a single weekly text sample, tokenization and linguistic annotation.

Feature extraction

Narrative features include:

Sentiment classification (positive, neutral, negative) Emotion probabilities for joy, sadness, anger, fear, surprise, and disgust using the pysentimiento library

Linguistic variables including:

type-token ratio, mean sentence length, proportion of first-person pronouns, proportion of past-tense verbs, obtained through udpipe

Semantic similarity measures between patient narratives and ACT-related prototype domains including:

experiential avoidance, cognitive fusion, rule-governed behavior, helplessness, achievement orientation, hopefulness

Semantic similarity is computed through cosine similarity between sentence-transformer embeddings and predefined prototype centroids.

Dimensionality reduction procedures using principal component analysis (PCA) are applied to selected linguistic and semantic variables to derive a principal component representing orientation toward internal emotional experience versus external contextual events.

Autoencoder Architecture

The multimodal model receives concatenated longitudinal feature vectors after robust scaling.

The architecture includes:

a bidirectional long short-term memory (BiLSTM) encoder, multi-head attention mechanisms, variational regularization using a β-variational autoencoder (β-VAE) framework, a decoder trained to reconstruct the original temporal feature sequence, and an auxiliary classification component predicting next-period clinical worsening.

The training objective combines:

mean squared reconstruction error, focal loss for classification, Kullback-Leibler divergence, and optional temporal smoothness regularization.

Model performance is evaluated using leave-one-patient-out cross-validation procedures. A final model may subsequently be trained using the complete dataset.

Primary Analyses

Primary analyses include:

evaluation of discriminative performance for prediction of subsequent clinical worsening using: area under the receiver operating characteristic curve (AUROC), area under the precision-recall curve (AUPRC), F1 score, Matthews correlation coefficient (MCC) examination of associations between latent trajectory representations and longitudinal psychometric changes, development of a Composite Clinical Risk Index (CCRI) derived from latent representations, and comparison of CCRI trajectories with weeks classified as clinical worsening according to predefined multimodal criteria.

Ethics and Dissemination

The study has received approval from the institutional review board of Under The Tree Miller A.C.

All participants provide written informed consent prior to participation.

Participation does not alter or replace standard residential treatment. All clinical decisions remain under the responsibility of treating professionals independent of study procedures.

Study findings will be submitted for publication in peer-reviewed scientific journals regardless of outcome. De-identified datasets and analysis code may be made available upon reasonable request and in accordance with institutional and ethical requirements.

Recruitment Status

Recruitment is ongoing. Final data collection for the primary outcome is anticipated in September 2026.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical diagnosis of severe substance use disorder (polydrug use, including cocaine, methamphetamines, alcohol, and/or cannabis), confirmed by the center's admission assessment.
  • Male sex (all participants in the center's residential program are male).
  • Age 18 years or older.
  • Current resident of the participating residential rehabilitation center in Mexico.
  • Completed at least four weeks of residential treatment at the time of study enrollment.
  • Able to write coherent weekly narratives in Spanish (no severe cognitive impairment or active psychosis).
  • Willing to provide written informed consent.

Exclusion criteria

  • Presence of acute psychotic symptoms that interfere with the ability to write or understand the study procedures.
  • Severe cognitive impairment (e.g., due to traumatic brain injury, intellectual disability) that prevents meaningful narrative production.
  • Inability to comply with weekly narrative writing (e.g., illiteracy, severe visual impairment).
  • Planned discharge from the residential program within less than 4 weeks from enrollment.
  • Enrollment in another interventional clinical trial that could confound the interpretation of outcomes.

Treatment and study plan

Residential rehabilitation as usual

Other

Participants follow the standard residential rehabilitation program provided by the center. This is a naturalistic exposure; the study does not impose any additional intervention. The "intervention" of interest is the routine therapeutic environment and its associated psychological processes (e.g., changes in avoidance, cognitive fusion, hope, and behavioral activation). These processes are measured through weekly written narratives and biweekly validated clinical scales (GAD-7, EROS, ATQ-8, BADS).

Primary outcomes

  1. Change in negative automatic thoughts measured by the Automatic Thoughts Questionnaire 8-item version

    Time frame: Every 2 weeks from baseline until discharge from residential treatment (up to 20 weeks)

    The Automatic Thoughts Questionnaire 8-item version is administered every two weeks. Total scores range from 8 to 40, with higher scores indicating more frequent negative automatic thoughts. The primary outcome is the change from baseline in total score over the course of residential treatment.

Secondary outcomes

  1. Change in generalized anxiety symptoms measured by the Generalized Anxiety Disorder 7 item scale

    Time frame: Every 2 weeks from baseline until discharge (up to 20 weeks)

    The Generalized Anxiety Disorder 7-item scale is administered every two weeks. Total scores range from 0 to 21, with higher scores indicating greater anxiety symptom severity.

  2. Change in environmental reward measured by the Environmental Reward Observation Scale

    Time frame: Every 2 weeks from baseline until discharge (up to 20 weeks)

    The Environmental Reward Observation Scale iis administered every two weeks. Total scores range from 10 to 40, with higher scores indicating greater exposure to positive environmental reinforcement.

  3. Change in behavioral activation and avoidance measured by the Behavioral Activation for Depression Scale

    Time frame: Every 2 weeks from baseline until discharge (up to 20 weeks)

    The Behavioral Activation for Depression Scale is administered every two weeks. Higher scores on the Activation subscale indicate greater engagement in goal-directed activity; higher scores on the Avoidance/Rumination subscale indicate greater behavioral avoidance and rumination.

  4. Weekly self-reported emotional intensity

    Time frame: Weekly from baseline until discharge (up to 20 weeks)

    Participants report the intensity of their predominant weekly emotion on a 0 to 10 numeric rating scale, where higher scores indicate greater emotional intensity.

  5. Weekly self-reported craving intensity

    Time frame: Weekly from baseline until discharge (up to 20 weeks)

    Participants rate average craving for substance use during the prior week on a 0 to 10 numeric rating scale, where higher scores indicate greater craving intensity.

Other outcomes

  1. Narrative sentiment valence index derived from weekly written narratives

    Time frame: Weekly from baseline until discharge (up to 20 weeks)

    Sentiment valence is calculated from weekly written narratives using a validated Spanish-language sentiment classification model. Scores range from -1 to +1, with lower scores indicating more negative emotional valence.

  2. Semantic similarity to Acceptance and Commitment Therapy-related constructs

    Time frame: Weekly from baseline until discharge (up to 20 weeks)

    Semantic similarity scores are computed between weekly narratives and prototype domains (e.g., experiential avoidance, cognitive fusion) using sentence embedding methods. Scores range from 0 to 1 (higher = greater similarity).

  3. Composite Clinical Risk Index derived from longitudinal narrative features

    Time frame: Weekly from baseline until discharge (up to 20 weeks)

    A composite longitudinal risk score is a composite longitudinal risk score calculated using multiple narrative-derived emotional variability indicators. Higher scores indicate greater estimated clinical vulnerability over time.

  4. Linguistic markers extracted from weekly written narratives

    Time frame: Weekly from baseline until discharge (up to 20 weeks)

    Linguistic variables including lexical diversity (type-token ratio), first-person pronoun frequency, and past-tense verb proportion are extracted from weekly written narratives using automated natural language processing (NLP) procedures.

Study contacts

Contact information is provided by the study sponsor or research team.

Lauro Gutiérrez Castro

CONTACT

[email protected]

+523314696107

Ricardo Fernandez

CONTACT

+52 1 33 1544 5474

Sponsors and collaborators

Lead sponsor

Lauro Gutiérrez Castro

Other

Registry information

Official study title

Analysis of Weekly Narratives Using Natural Language Processing in Patients Undergoing Residential Rehabilitation: A Hybrid Approach for the Dynamic Assessment of Clinical Processes

Acronym: DYNA-NLP

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
May 19, 2026
Registry last updated
May 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.